<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

    <!-- SEO -->
    <meta name="description" content="Automated dose-response analysis with CellPyAbility">
    <meta name="keywords" content="James Elia, project, project2, cellpyability, nuclei, python">
    <meta name="author" content="James L. Elia">
    <meta name="robots" content="index, follow">
    <link rel="canonical" href="https://www.jlelia.net/project2">

    <!-- Site Icons -->
    <link rel="icon" href="/images/favicon.ico" type="image/x-icon">
    <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon">
    <link rel="apple-touch-icon" sizes="180x180" href="/images/apple-touch-icon.png">

    <!-- Open Graph Meta Tags -->
    <meta property="og:title" content="Project #2 – James L. Elia">
    <meta property="og:description" content="Automating dose-response analysis with CellPyAbility.">
    <meta property="og:image" content="https://www.jlelia.net/images/gda.webp">
    <meta property="og:url" content="https://www.jlelia.net/project2">
    <meta property="og:type" content="website">

    <!-- PWA / Mobile Enhancements -->
    <link rel="manifest" href="/site.webmanifest">
    <meta name="theme-color" content="#ffffff">

  <!-- Performance Optimizations -->
  <link rel="preload" as="image" href="/images/headshot.webp" imagesrcset="/images/headshot.webp 1x" fetchpriority="high">
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600;700&display=swap" rel="stylesheet">
  <link rel="stylesheet" href="/styles.css">

    <title>Project #2 - James L. Elia</title>
  </head>
  <body>
    <header>
      <div class="header-inner container">
  <div class="brand-group">
          <img src="/images/headshot.webp" alt="James L. Elia headshot" class="headshot" width="75" height="75">
          <h1>James L. Elia</h1>
        </div>
        <nav aria-label="Primary">
          <a href="/">Home</a>
          <a href="/about">About</a>
          <a href="/publications">Publications</a>
          <a href="/projects">Projects</a>
          <a href="/blog">Blog</a>
        </nav>
      </div>
    </header>
  
    <main>
      <h2>Project #2: CellPyAbility - High-Throughput Dose-Response Screening</h2>
      <h3><a href="https://github.com/bindralab/cellpyability" target="_blank" rel="noopener">GitHub Repo</a></h3>

      <div class="tech-stack">
        <p><strong>Stack:</strong> Python 3 • CellProfiler • PyInstaller • SciPy • Plotly • GitHub Actions</p>
      </div>

      <p>
        <strong>Objective</strong>: Improve cell viability analysis by automating high-throughput nuclei counting and statistical modeling. Open-sourced and available as a
        code-free Windows application.
      </p>
      <p>
        Featured in <a href="https://medicine.yale.edu/news-article/meet-cellpyability-a-new-tool-developed-at-yale-to-accelerate-cancer-drug-discovery/" target="_blank" rel="noopener">Yale School of Medicine News</a>.
      </p>

      <h3>Nuclei Counting is Superior to Metabolic Proxies</h3>
      <p>
       Standard high-throughput screenings often rely on metabolic proxies (e.g. tetrazolium reduction or ATP content) to estimate cell death. While fast, these methods are often confounded by metabolic variability or redox-active drugs.
       Further, they lack cell-level resolution, giving a single fluorescent value per well that often loses linearity.
      </p>
      <p>
        <strong>Direct nuclei counting</strong> offers a ground-truth measurement of survival with single-cell resolution and higher accuracy. However, the computational cost of analyzing high-content images typically forces researchers back 
        to inferior metabolic proxies. <strong>CellPyAbility</strong> eliminates this trade-off, processing 60 whole-well images in under one minute on commodity hardware.
      </p>

      <h3>Software Architecture and Accessibility</h3>
      <p>
        To ensure accessibility across the technical spectrum, I engineered a dual-architecture distribution:
      </p>
      <ul>
        <li><strong>For Computational Biologists:</strong> A modular Python package (available via PyPI and Bioconda) integrating <strong>CellProfiler</strong> for headless image segmentation and <strong>NumPy/Pandas/SciPy</strong> for statistical analysis.</li>
        <li><strong>For Bench Scientists:</strong> A standalone, code-free Windows executable (built with <strong>PyInstaller</strong>) that bundles the Python runtime and dependencies, requiring no distribution or coding knowledge.</li>
      </ul>

      <h3>Mathematical Implementation</h3>
      <p>
        The suite consists of two core analytical modules designed for robust statistical inference:
      </p>
      <ul>
        <li><strong>Logistic Regression:</strong> The GDA module fits dose-response curves using a <strong>5-parameter logistic (5PL)</strong> model, then solves for the IC50 for each condition. Depending on the experiment, the ratio of IC50s can be used as an approximate therapeutic index.</li>
        <li><strong>Synergy Modeling:</strong> The Synergy module models 59 unique drug interactions per experiment. It calculates <strong>Bliss Independence scores</strong> and renders interactive <strong>3D surface maps</strong> using Plotly to visualize synergistic volumes.</li>
      </ul>

      <figure style="text-align: center;">
         <img src="/images/mmc.webp" alt="Dose-response curves showing IC50 shifts" class="content-image" loading="lazy">
         <figcaption>
            <strong>Automated GDA Analysis:</strong> CellPyAbility output quantifying the sensitivity of BRCA2-deficient cells to Mitomycin C. BRCA2-deficient cells cannot perform 
            homologous recombination effectively, leading to increased sensitivity to DNA-crosslinking agents.
         </figcaption>
      </figure>
      <figure style="text-align: center;">
         <img src="/images/synergy.webp" alt="3D Surface map of drug synergy" class="content-image" loading="lazy">
         <figcaption>
            <strong>Synergy Modeling:</strong> A 3D Bliss Independence surface map visualizing the interaction between CB1954 and NRH, a prodrug and its bioactivating cofactor.
         </figcaption>
      </figure>

      <div class="project-navigation">
        <a class="nav-left" href="/project1">← Project #1</a>
        <a class="nav-right" href="/project3">Project #3 →</a>
      </div>
    </main>
  
    <footer>
      <p>&copy; 2026 James L. Elia</p>
    </footer>
  </body>
    